Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)
National Institutes of Health Nationwide (Federal)
Tell us about your organization and we'll show you whether this grant fits, and why.
Free to start. No credit card required.
Deadline
November 15, 2027
Region
Nationwide (Federal)
Funder type
Federal Government
For
Nonprofits & businesses
Sectors
Health & Human Services
About this program
Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional) — U.S. federal funding opportunity (PAR-25-311) from National Institutes of Health. See grants.gov for full eligibility and details.
Is this grant worth your time?
Create a free account and Happy Grants scores this program, and 2,300+ others, against your organization’s profile in about a minute, with the reasons explained.
See your match score, freeSimilar grants
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)National Institutes of Health Nov 18, 2026
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)National Institutes of Health Nov 18, 2026
- Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)National Institutes of Health May 4, 2028
- Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)National Institutes of Health Dec 2, 2026
- Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional)National Institutes of Health Jul 7, 2028
- BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)National Institutes of Health Feb 8, 2029


